Patents by Inventor Jeff Dantzler

Jeff Dantzler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
    Publication number: 20220112295
    Abstract: Provided are compositions and methods relating to human CD30L antigen binding proteins Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions Methods of making and using each of these compositions are also provided.
    Type: Application
    Filed: October 22, 2021
    Publication date: April 14, 2022
    Inventors: METTE D. ANDERSEN, JEFF DANTZLER, RICHARD J. ARMITAGE, RUTILIO CLARK
  • Human CD30 Ligand Antigen Binding Proteins
    Publication number: 20180298105
    Abstract: Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions. Methods of making and using each of these compositions are also provided.
    Type: Application
    Filed: February 27, 2018
    Publication date: October 18, 2018
    Inventors: Mette D. Andersen, Jeff Dantzler, Richard J. Armitage, Rutillio Clark
  • Human CD30 ligand antigen binding proteins
    Patent number: 9926373
    Abstract: Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions. Methods of making and using each of these compositions are also provided.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: March 27, 2018
    Assignees: Novo Nordisk A/S, Amgen Inc.
    Inventors: Mette D. Andersen, Jeff Dantzler, Richard J. Armitage, Rutilio Clark
  • Human CD30 Ligand Antigen Binding Proteins
    Publication number: 20160039940
    Abstract: Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions. Methods of making and using each of these compositions are also provided.
    Type: Application
    Filed: April 25, 2013
    Publication date: February 11, 2016
    Applicants: AMGEN INC., NOVO NORDISK A/S
    Inventors: Mette D. Andersen, Jeff Dantzler, Richard J. Armitage, Rutilio Clark